iBio (IBIO) Insider Trading & Ownership $2.19 -0.04 (-1.79%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartFinancialsHeadlinesInsider TradesSEC Filings iBio (NYSEMKT:IBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.58%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$64,609.40 Get IBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling iBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IBIO Insider Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW iBio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/2/2023Martin BrennerInsiderSell210$6.20$1,302.00 8/28/2023Martin BrennerInsiderSell250$6.20$1,550.00 7/27/2023Martin BrennerInsiderSell225$10.20$2,295.00 7/12/2023Martin BrennerInsiderSell2,351$11.80$27,741.80 6/21/2023Martin BrennerInsiderSell209$13.60$2,842.40 5/22/2023Martin BrennerInsiderSell209$18.80$3,929.20 4/24/2023Martin BrennerInsiderSell219$24.00$5,256.00 3/23/2023Martin BrennerInsiderSell260$42.60$11,076.00 3/10/2022Robert Matthew LutzInsiderSell1,231$7.00$8,617.00 (Data available from 1/1/2013 forward) IBIO Insider Trading Activity - Frequently Asked Questions Who is on iBio's Insider Roster? The list of insiders at iBio includes Martin Brenner, and Robert Matthew Lutz. Learn more on insiders at IBIO. What percentage of iBio stock is owned by insiders? 0.58% of iBio stock is owned by insiders. Learn more on IBIO's insider holdings. Which iBio insiders have been selling company stock? The following insider sold IBIO shares in the last 24 months: Martin Brenner ($55,992.40). How much insider selling is happening at iBio? Insiders have sold a total of 3,933 iBio shares in the last 24 months for a total of $55,992.40 sold. iBio Key ExecutivesDr. Martin B. Brenner D.V.M. (Age 54)Ph.D., CEO, Chief Scientific Officer & Director Compensation: $753kMr. Felipe Duran (Age 45)Chief Financial Officer Compensation: $513.22kMr. Marc Banjak J.D.Chief Legal OfficerMs. Kristi SarnoSenior VP of Business Development More Insider Trading Tools from MarketBeat Related Companies CLSD Insider Buying EPIX Insider Buying FBLG Insider Buying PDSB Insider Buying HOWL Insider Buying AVTE Insider Buying ZIVO Insider Buying VNRX Insider Buying OVID Insider Buying VTGN Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NYSEMKT:IBIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
